Shanghai Model Organisms Center, Inc. (688265.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
777
First IPO Date
December 28, 2021
| Name | Title | Pay | Year Born |
| Mingjun Wang | GM, Acting Chief Financial Officer, Accounting Supervisor & Director | 0 | 1972 |
| Wen Liu | Secretary of the Board of Directors | 0 | 1990 |
| Dongxiao Feng | Deputy General Manager | 0 | 1970 |
| Ruilin Sun | Deputy General Manager | 0 | 1980 |
Shanghai Model Organisms Center, Inc. (SMOC) is a prominent Chinese enterprise dedicated to the research and development of genetically engineered animal models. The company offers a broad spectrum of specialized rodent models, encompassing disease-specific, humanized, immunodeficient, tool, and fluorescent reporter strains of both mice and rats. Furthermore, SMOC produces custom cellular products, including fluorescently labeled, primary, and humanized cell lines. Beyond its core product offerings, SMOC delivers a comprehensive suite of support services. These include personalized model generation, animal husbandry and breeding programs, in-depth phenotypic analysis, and critical drug screening and evaluation services for preclinical research. Established in 2000, SMOC maintains its primary operations and corporate headquarters in Shanghai, China.